The first CTI BioPharma trade was made in Q2 2022.
Since then Steven Cohen bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in CTI BioPharma anymore.
Avg closing price
Price range
Sold -1.76 Million shares
Q1 2023
Avg closing price
$5.19
Price range
$4.20
-
$6.01
Increased shares by 1529.0% (+1.65 Million shares)
Q4 2022